Figure 3From: Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acidEffect of Zol on the mevalonate pathway and on proliferation markers. A) Western blot analyses. B) Ras activity evaluated by western blot. C) Band density quantifications by Quantity one software.Back to article page